GlassScriptPhysician profile
Marc Heller
NPI 1225169808
$5,944.13
in general payments reported to CMS, 2019-2025
32 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $721 · 2021: $2,004 · 2022: $514 · 2023: $566 · 2024: $394 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,208.65 | 2021 | |
| Lilly USA, LLC | $731.28 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $484.55 | 2019-2025 | Rybelsus, Wegovy, Ozempic |
| Abbvie INC. | $478.27 | 2021-2024 | |
| Amarin Pharma, INC. | $372.08 | 2019-2022 | |
| Glaxosmithkline, LLC. | $366.28 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $327.50 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $298.28 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $275.05 | 2019-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.08 | 2019-2025 | Jardiance |
| Allergan, INC. | $148.89 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $139.63 | 2019-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $136.84 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.00 | 2019 | |
| Abbott Laboratories | $75.97 | 2020-2023 | Freestyle Libre 3 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $74.08 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $70.19 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.34 | 2024 | |
| Amgen INC. | $56.15 | 2020-2024 | Repatha, Otezla |
| Exact Sciences Corporation | $41.05 | 2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $38.96 | 2024-2025 | Inspire |
| Boston Scientific Corporation | $36.65 | 2025 | Wavewriter Alpha Prime 16 |
| Hologic Sales and Service, LLC | $33.59 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Eisai INC. | $31.00 | 2024 | |
| Astellas Pharma US INC | $29.04 | 2019-2021 | |
| Echosens North America, INC. | $25.75 | 2025 | Fibroscan |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $21.34 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.10 | 2022 | |
| Tactile Systems Technology INC | $18.79 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $18.13 | 2020 | |
| Genentech USA, INC. | $15.29 | 2020 | |
| Currax Pharmaceuticals LLC | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.